cancer genetics inc
(CGIX:Consolidated Issue listed on NASDAQ Capital Market)
Hans-Guido Wendel M.D.
Member of Scientific Advisory Board,Cancer Genetics, Inc.
|Age||Total Calculated Compensation||This person is connected to 30 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Hans-Guido Wendel, M.D. is a Principal Investigator at the Cancer Genetics Laboratory at Memorial Sloan-Kettering Cancer Center, which is focused on the genetics of cancer and using its findings on the cancer genome to develop better diagnostic and treatment approaches that improves the care of cancer patients. Dr. Wendel has been Member of Scientific Advisory Committee at Egenix, Inc. since May 2014. He serves as a Member of Scientific Advisory Board at Cancer Genetics, ...
201 Route 17 NorthPhone: 201-528-9200
Rutherford, New Jersey 07070
Board Members Memberships*There is no Board Members Memberships data available.
Rheinisch-Westfälische Technische Hochschule Aachen
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Douglas M. VanOort||Executive Chairman and Chief Executive Officer|
|Kenneth A. Berlin||Chief Executive Officer and President|
Rosetta Genomics, Ltd.
|Kimberly J. Popovits||Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee|
Genomic Health Inc.
|Thomas A. Bologna||Chairman and Chief Executive Officer|
Response Genetics, Inc
|Michael J. Pellini M.D., MBA||Chief Executive Officer and Director|
Foundation Medicine, Inc.
|$416.0K||Compensation as of Fiscal Year 2014.|